An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm
Movement Disorders · 2024-04 · 39 (4) · 738-745
DOI: 10.1002/mds.29734 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, online erschienen am 03.02.2024. Verfasst von Gamze Kilic-Berkmen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Blepharospasm. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Background
Blepharospasm is treated with botulinum toxin, but obtaining satisfactory results is sometimes challenging.
Objective
The aim is to conduct an exploratory trial of oral dipraglurant for blepharospasm.
Methods
This study was an exploratory, phase 2a, randomized, double‐blind, placebo‐controlled trial of 15 participants who were assigned to receive a placebo or dipraglurant (50 or 100 mg) and assessed over 2 days, 1 and 2 hours following dosing. Outcome measures included multiple scales rated by clinicians or participants, digital video, and a wearable sensor.
Results
Dipraglurant was well tolerated, with no obvious impact on any of the measurement outcomes. Power analyses suggested fewer subjects would be required for studies using a within‐subject versus independent group design, especially for certain measures. Some outcome measures appeared more suitable than others.
Conclusion
Although dipraglurant appeared well tolerated, it did not produce a trend for clinical benefit. The results provide valuable information for planning further trials in blepharospasm. © 2024 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of IEN Center for Human-Centric Interfaces and Engineering, The Institute for Electronics and Nanotechnology, Georgia Institute of Technology, Atlanta, Georgia, USA.
- Department of George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
- Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
- Departments of Parker H. Petit Institute for Bioengineering and Biosciences, Institute for Materials, Neural Engineering Center, Institute for Robotics and Intelligent Machines, Georgia Institute of Technology, Atlanta,…
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech and Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Gamze Kilic-Berkmen, Laura M Scorr, David A Peterson
Förderung
- NINDS NIH HHS
- NCATS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Kilic-Berkmen, G., Kim, H., Chen, D., Yeo, C. I., Dinasarapu, A. R., Scorr, L. M., Yeo, W. H., Peterson, D. A., Williams, H., Ruby, A., Mills, R., & Jinnah, H. A. (2024). An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm. Movement Disorders, 39(4), 738-745. https://doi.org/10.1002/mds.29734
Vancouver
Kilic-Berkmen G, Kim H, Chen D, Yeo CI, Dinasarapu AR, Scorr LM, et al. An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm. Movement Disorders. 2024;39(4):738-745. doi:10.1002/mds.29734
BibTeX
@article{KilicBerkmen2024,
author = {Kilic-Berkmen, Gamze and Kim, Hodam and Chen, Dongdong and Yeo, Cameron I and Dinasarapu, Ashok R and Scorr, Laura M and Yeo, Woon-Hong and Peterson, David A and Williams, Hilde and Ruby, April and Mills, Roger and Jinnah, H A},
title = {An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {4},
pages = {738--745},
doi = {10.1002/mds.29734}
}
EUVIMED